Grantz Katherine L, Lee Wesley, Mack Lauren M, Sanz Cortes Magdalena, Goncalves Luis F, Espinoza Jimmy, Newman Roger B, Grobman William A, Wapner Ronald J, Fuchs Karin, D'Alton Mary E, Skupski Daniel W, Owen John, Sciscione Anthony, Wing Deborah A, Nageotte Michael P, Ranzini Angela C, Chien Edward K, Craigo Sabrina, Sherman Seth, Gore-Langton Robert E, He Dian, Tekola-Ayele Fasil, Zhang Cuilin, Grewal Jagteshwar, Chen Zhen
Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX.
Am J Obstet Gynecol. 2025 Mar;232(3):324.e1-324.e160. doi: 10.1016/j.ajog.2024.05.049. Epub 2024 Jun 3.
A major goal of contemporary obstetrical practice is to optimize fetal growth and development throughout pregnancy. To date, fetal growth during prenatal care is assessed by performing ultrasonographic measurement of 2-dimensional fetal biometry to calculate an estimated fetal weight. Our group previously established 2-dimensional fetal growth standards using sonographic data from a large cohort with multiple sonograms. A separate objective of that investigation involved the collection of fetal volumes from the same cohort.
The Fetal 3D Study was designed to establish standards for fetal soft tissue and organ volume measurements by 3-dimensional ultrasonography and compare growth trajectories with conventional 2-dimensional measures where applicable.
The National Institute of Child Health and Human Development Fetal 3D Study included research-quality images of singletons collected in a prospective, racially and ethnically diverse, low-risk cohort of pregnant individuals at 12 U.S. sites, with up to 5 scans per fetus (N=1730 fetuses). Abdominal subcutaneous tissue thickness was measured from 2-dimensional images and fetal limb soft tissue parameters extracted from 3-dimensional multiplanar views. Cerebellar, lung, liver, and kidney volumes were measured using virtual organ computer aided analysis. Fractional arm and thigh total volumes, and fractional lean limb volumes were measured, with fractional limb fat volume calculated by subtracting lean from total. For each measure, weighted curves (fifth, 50th, 95th percentiles) were derived from 15 to 41 weeks' using linear mixed models for repeated measures with cubic splines.
Subcutaneous thickness of the abdomen, arm, and thigh increased linearly, with slight acceleration around 27 to 29 weeks. Fractional volumes of the arm, thigh, and lean limb volumes increased along a quadratic curvature, with acceleration around 29 to 30 weeks. In contrast, growth patterns for 2-dimensional humerus and femur lengths demonstrated a logarithmic shape, with fastest growth in the second trimester. The mid-arm area curve was similar in shape to fractional arm volume, with an acceleration around 30 weeks, whereas the curve for the lean arm area was more gradual. The abdominal area curve was similar to the mid-arm area curve with an acceleration around 29 weeks. The mid-thigh and lean area curves differed from the arm areas by exhibiting a deceleration at 39 weeks. The growth curves for the mid-arm and thigh circumferences were more linear. Cerebellar 2-dimensional diameter increased linearly, whereas cerebellar 3-dimensional volume growth gradually accelerated until 32 weeks followed by a more linear growth. Lung, kidney, and liver volumes all demonstrated gradual early growth followed by a linear acceleration beginning at 25 weeks for lungs, 26 to 27 weeks for kidneys, and 29 weeks for liver.
Growth patterns and timing of maximal growth for 3-dimensional lean and fat measures, limb and organ volumes differed from patterns revealed by traditional 2-dimensional growth measures, suggesting these parameters reflect unique facets of fetal growth. Growth in these three-dimensional measures may be altered by genetic, nutritional, metabolic, or environmental influences and pregnancy complications, in ways not identifiable using corresponding 2-dimensional measures. Further investigation into the relationships of these 3-dimensional standards to abnormal fetal growth, adverse perinatal outcomes, and health status in postnatal life is warranted.
当代产科实践的一个主要目标是在整个孕期优化胎儿生长发育。迄今为止,产前检查期间胎儿生长情况是通过二维超声测量胎儿生物测量值来计算估计胎儿体重进行评估的。我们的团队之前利用来自一个有多次超声检查的大型队列的超声数据建立了二维胎儿生长标准。该研究的另一个目标是收集同一队列的胎儿体积数据。
胎儿三维研究旨在通过三维超声建立胎儿软组织和器官体积测量标准,并在适用情况下将生长轨迹与传统二维测量方法进行比较。
美国国立儿童健康与人类发展研究所胎儿三维研究纳入了在美国12个地点收集的单胎研究质量图像,这些图像来自一个前瞻性、种族和民族多样化的低风险孕妇队列,每个胎儿最多进行5次扫描(N = 1730例胎儿)。从二维图像测量腹部皮下组织厚度,并从三维多平面视图中提取胎儿肢体软组织参数。使用虚拟器官计算机辅助分析测量小脑、肺、肝和肾的体积。测量上肢和大腿的总体积分数以及瘦肢体体积分数,并通过从总体积中减去瘦体积来计算肢体脂肪体积分数。对于每项测量,使用带有三次样条的重复测量线性混合模型,得出15至41周的加权曲线(第5、50、95百分位数)。
腹部、上肢和大腿的皮下厚度呈线性增加,在27至29周左右略有加速。上肢、大腿和瘦肢体体积分数呈二次曲线增加,在29至30周左右加速。相比之下,二维肱骨和股骨长度的生长模式呈对数形状,在孕中期生长最快。上臂中部面积曲线形状与上肢体积分数相似,在30周左右加速,而瘦上臂面积曲线则较为平缓。腹部面积曲线与上臂中部面积曲线相似,在29周左右加速。大腿中部和瘦面积曲线与上臂面积曲线不同,在39周时出现减速。上臂中部和大腿周长的生长曲线更呈线性。小脑二维直径呈线性增加,而小脑三维体积生长在32周前逐渐加速,之后增长更呈线性。肺、肾和肝体积在早期均呈逐渐增长,随后肺从25周开始、肾从26至27周开始、肝从29周开始呈线性加速。
三维瘦组织和脂肪测量、肢体和器官体积的生长模式及最大生长时间与传统二维生长测量方法所揭示的模式不同,表明这些参数反映了胎儿生长的独特方面。这些三维测量中的生长可能会受到遗传、营养、代谢或环境影响以及妊娠并发症的改变,而这些是使用相应二维测量方法无法识别的。有必要进一步研究这些三维标准与胎儿生长异常、围产期不良结局以及出生后健康状况之间的关系。